| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |